EFFECT OF COGNITIVE BEHAVIORAL THERAPY ON DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH POST COVID-19
NCT ID: NCT05981872
Last Updated: 2023-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
36 participants
INTERVENTIONAL
2023-05-04
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• Is a cognitive rehabilitation therapy will improve depression and quality of life in patients with post COVID-19? Researchers will compare Rehacom with exercise therapy to see if rehacom can improve depression and quality of life in patients with post COVID-19 neuropsychological problems.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computer Cognitive Training for Post-acute COVID-19 Syndrome
NCT05338749
Cognitive Rehabilitation Therapy for COVID-19
NCT06086379
Computerized Training of Attention and Working Memory in Post COVID-19 Patients With Cognitive Complaints
NCT05831839
Cognitive Rehabilitation for Long COVID
NCT05676047
Efficacy of Cognitive Behavioral Therapy on Fatigue, Cognition and Inflammatory Biomarkers in MS Patients
NCT05002062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To investigate the effect of cognitive rehabilitation therapy on depression in post COVID-19 patients.
* To investigate the effect of cognitive rehabilitation therapy on quality of life in post COVID-19 patients.
Significance of the study:
•There is growing evidence that individuals with COVID-19 disease can develop a range of neurological complications including cognitive and neuropsychiatric symptoms . Cognitive rehabilitation essential in improving quality of life with Introduction of new neuropsychological rehabilitation tools based on the latest developments in computer sciences.
This study aims to investigate the RehaCom as a cognitive rehabilitation program on depression and quality of life in patients suffer from post COVID-19 neuropsychological problems.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Control group (B) which will include 18 patients who will receive only selected physical therapy program
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
post covid-19 patients with neurological symptoms as study group
•Study group (A) will receive cognitive rehabilitation (Rehacom ) for 30 minutes and selected physical therapy program(that included aerobic, strength, and balance training for 30 minutes, with total duration 60 minutes. 3 sessions per week for 12 weeks.
rehacom
Rehacom was carried out at the cognition laboratory at Faculty of physical therapy, Cairo University for training of figural memory, attention concentration.
1. Attention concentration training consists of 24 levels of difficulties .
2. Figural memory training consists of 9 levels of difficulties. In the training session, every patient was starting training from level one and when the patient successfully finished the level, the training then Progress to the level of difficulty.
post covid-19 patients with neurological symptoms as control group
Control group (B) which will include 18 patients who will receive only selected physical therapy program (that included aerobic, strength, and balance training ).
The treatment will conducted for 60 minutes, 3 sessions per week for 12 weeks
rehacom
Rehacom was carried out at the cognition laboratory at Faculty of physical therapy, Cairo University for training of figural memory, attention concentration.
1. Attention concentration training consists of 24 levels of difficulties .
2. Figural memory training consists of 9 levels of difficulties. In the training session, every patient was starting training from level one and when the patient successfully finished the level, the training then Progress to the level of difficulty.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rehacom
Rehacom was carried out at the cognition laboratory at Faculty of physical therapy, Cairo University for training of figural memory, attention concentration.
1. Attention concentration training consists of 24 levels of difficulties .
2. Figural memory training consists of 9 levels of difficulties. In the training session, every patient was starting training from level one and when the patient successfully finished the level, the training then Progress to the level of difficulty.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Patients from both genders (male and female).
2. The age of participants ranged from 30 to 45 years .
3. The patients had score more than 24 according to Mini mental state examination (MMSE).
4. Patient muscle power not less than grade 3 .
5. Patients are ambulant.
6. Patients with confirmation of previous covid19 infection PCR TEST.
7. Participants were required to live in Egypt during the pre-covid and COVID-19 pandemic.
8. Patients meeting the guide line of world health organization (WHO) of long/post-covid 19 syndromes.
9. Patients are "long-haulers" those who history of probable or confirmed SARS-CoV-2 infection; usually within three months from the onset of COVID-19, and last more than two months
Exclusion Criteria
1. Patient previously diagnosed with depression and currently taking medication.
2. patient had prior cognitive impairment.
3. Illiterate patients.
4. patient had experienced another major stressful event (e.g., divorce, bereavement) in the past year.
5. Checking comorbidities (sum of hypertension, diabetes, arrhythmia, myocardial infarction, Chronic Obstructive Pulmonary Disease/Asthma.
6. Mild cognitive impairment, dementia, other neurodegenerative diseases, stroke, depression,
7. Osteoarthritis , low back pain and prevalence of polypharmacy (5 or more drugs) at admission.
30 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Allaa Ashraf Maher Mohammed Elfwey
physical therapist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hossam M Mohammed, PHD
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of physical therapy .Cairo university
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Rehacom on post covid
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.